Armistice Capital’s Sonnet BioTherapeutics SONN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-34,000
Closed -$255K 314
2024
Q2
$255K Buy
+34,000
New +$255K ﹤0.01% 192